Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors

BACKGROUND: Nephrotoxicity is the major side effect that limits the dose of cisplatin that can be safely administered, and it is a clinical problem in cancer patients who received cisplatin combination chemotherapy. Recent evidence has demonstrated that patients with chronic kidney disease (CKD) hav...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:BMC Cancer
Main Authors: Sato, Ko, Watanabe, Satoshi, Ohtsubo, Aya, Shoji, Satoshi, Ishikawa, Daisuke, Tanaka, Tomohiro, Nozaki, Koichiro, Kondo, Rie, Okajima, Masaaki, Miura, Satoru, Tanaka, Junta, Sakagami, Takuro, Koya, Toshiyuki, Kagamu, Hiroshi, Yoshizawa, Hirohisa, Narita, Ichiei
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2016
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4793503/
https://ncbi.nlm.nih.gov/pubmed/26979596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2271-8
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים